Select a product below to customize your system
t:slim X2 Insulin Pump
A variety of
accessories for the
sleek, modern,
all‑in‑one system.
Tandem Mobi System
Check out some
of the accessories for
the tiny pump that's big
on control.
Adhesive Sleeve
Buy the Tandem Mobi adhesive sleeve for on-body wear. Visit the Tandem Source Store.
Tandem Diabetes Care teams up with companies that are committed to improving the lives of people with diabetes. Check out some of these trusted partners for accessories.*
Pump Peelz
Shop thousands of designs, or create a
custom image, on medical-grade materials to
personalize your pump.
Sugar Medical
Tandem-licensed accessories
that help you stay organized and
protect your devices.
Deck My Diabetes
Innovative accessories designed
to protect, personalize, and empower
your diabetes journey.
Skin Grip
Performance adhesive patches built to
keep Tandem devices secure through sweat,
water, and real life.
* The products featured on this page are manufactured and sold by independent third-party companies. Tandem Diabetes Care, Inc. does not design, manufacture, or test these products and makes no representations or warranties regarding their quality, performance, or suitability for use with Tandem Diabetes Care insulin pumps or other devices. Any concerns, claims, or issues related to these products should be directed to the respective manufacturer. Tandem Diabetes Care, Inc. is not responsible or liable for any damages, malfunctions, or outcomes that may result from the use of these third-party products.
Important Safety Information
RX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog, Humalog, or Lyumjev U-100 insulin. The Tandem Mobi insulin pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin.
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater. Control-IQ+ technology is intended for use in pregnancy complicated by type 1 diabetes mellitus, provided the linked CGM system is suitable for use in pregnancy.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.